Adaxion Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6175 Nancy Ridge Dr, San Diego, Californ...Website
www.adaxiontx.comRevenue
<$5 MillionIndustry
About Adaxion Therapeutics
Adaxion Therapeutics Org Chart
Is Adaxion Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Adaxion Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Adaxion Therapeutics launches new products
Adaxion Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Adaxion Therapeutics has new funding data
Earning: See what the market has to say on Adaxion Therapeutics recently announced quarterly report
Check out if Adaxion Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Adaxion Therapeutics
Click to see if Adaxion Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Adaxion Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Adaxion Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adaxion Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adaxion Therapeutics.
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adaxion Therapeutics
Adaxion Therapeutics focuses on overcoming the immunogenicity challenges in biotherapeutics by utilizing its proprietary platform technology. Their innovative approach features CD22 ligands integrated into biologics to eliminate therapeutic-specific B cells while preserving their efficacy. The company aims to develop a new generation of biologic th... Read More
